Kinarus Therapeutics Statements
FM
Data from Kinarus Therapeutics`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
CHF - Swiss franc
Last reporting period:
30 Jun, 2023
Next reporting period:
27 Dec, 2023
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
—
Kinarus Therapeutics Income Statement
B
M
CHF (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
—
100
—
0
—
—
0
0.272
0
1.349
0
1.944
125 %
0
-1.944
-125 %
0
-0.005
0
—
0
-2.092
94.6 %
0
-0.041
0
-2.051
94 %
0
-0.002
1 195.1
—
—
100
—
0
—
—
0
1.271
0
1.624
0
0.864
-11.5 %
0
-0.864
11.5 %
0
-0.008
0
—
0
-39.049
-4494 %
0
-5.128
0
-33.937
-4168.8 %
0
-0.031
1 098.43
—
—
100
—
0
—
—
0
0.236
0
0.523
0
0.976
484.4 %
0
-0.976
-484.4 %
0
0.126
0
—
0
-0.85
-383 %
0
-0.028
0
-0.795
-351.7 %
0
-0.003
305.78
—
—
100
—
0
—
—
0
—
0
0.167
0
0.167
-31.3 %
0
-0.167
31.3 %
0
-0.009
0
—
0
-0.176
-633.3 %
0
—
0
-0.176
-633.3 %
0
-0.001
163.77
—
-100 %
100
—
0
—
-100 %
0
—
0
0.243
0
0.243
-77.2 %
0
-0.243
55.3 %
0
0.276
0
—
0
0.033
571.4 %
0
—
0
0.033
571.4 %
0
0
163.77
4.109
-3.1 %
100
3.588
87.3
0.521
-3.2 %
12.7
—
0
1.074
26.1
1.065
19.5 %
25.9
-0.544
-54.1 %
-13.2
1.098
26.7
—
0
-0.007
-103.7 %
-0.2
—
0
-0.007
-103.7 %
-0.2
0
168.43
4.24
-55.8 %
100
3.702
87.3
0.538
-51.6 %
12.7
—
0
0.9
21.2
0.891
-35.5 %
21
-0.353
-30.7 %
-8.3
1.101
26
—
0
0.187
157 %
4.4
—
0
0.187
157.2 %
4.4
0.001
173.15
9.603
—
100
8.492
88.4
1.111
—
11.6
—
0
1.368
14.2
1.381
—
14.4
-0.27
—
-2.8
-0.058
-0.6
—
0
-0.328
—
-3.4
-0.001
-0.01
-0.327
—
-3.4
-0.002
181.02